In recent years, research into cannabis and its main psychoactive ingredient, Δ⁹-tetrahydrocannabinol (THC), has unearthed ...

In A Nutshell A mouse study found that low-dose THC combined with celecoxib protected memory and reduced brain damage linked to Alzheimer’s. THC alone reduced toxic proteins but also increased ...

Combining low-dose THC and celecoxib improved cognition and reduced Alzheimer's-related brain pathology in mice. | Cannabis ...

New research suggests THC’s cognitive drawbacks may be mitigated when combined with a targeted anti-inflammatory drug. Cannabis research has highlighted a scientific paradox. Its best-known ...

Alzheimer’s disease has long resisted simple solutions, but a new line of research suggests an unexpected pairing could help keep the condition at bay: a marijuana-derived compound working alongside a ...

NEW ORLEANS, LA — A long-awaited trial suggests the selective cyclooxygenase-2 (COX-2) inhibitor celecoxib has similar cardiovascular safety as naproxen and ibuprofen in arthritis patients at ...

The US Food and Drug Administration (FDA) today approved the first generic versions of the anti-inflammatory drug celecoxib (Celebrex, Pfizer) in the wake of legal wrangling between the brand-name ...

Second-line chemotherapy with cyclophosphamide, doxorubicin and vincristine (CAV) in patients with small cell lung cancer (SCLC) initially treated with platinum and etoposide ...

NEW YORK (Reuters Health) - People who took a newer type of pain pill over a three-year period were less likely to develop polyps that could lead to colorectal cancer -- but at the expense of a higher ...

Temporal trends of mortality due to laryngeal cancer among older adults in United States: A CDC WONDER analysis on gender, race, and geographical disparities. This is an ASCO Meeting Abstract from the ...